Form 4 Tracker
Zai Lab Ltd
ZLAB

27 insider filings · Latest: May 26, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
May 18, 2026May 19 8:18 PMYing DuDirector, Chairperson & CEO
Sale
50,000$19.00$949.8K1,122,626(D)

View →

May 15, 2026May 19 8:18 PMYing DuDirector, Chairperson & CEO
Sale
50,000$20.74$1.0M1,122,626(D)

View →

May 18, 2026May 18 3:34 PMDu Ying
Proposed Sale
50,000$19.52$976.0K

View →

May 14, 2026May 15 8:46 PMFrazor Titus Edmondson IIIChief Legal Officer
Sale
3,517$20.19$71.0K19,849(D)

View →

May 14, 2026May 15 8:45 PMYing DuDirector, Chairperson & CEO
Sale
50,000$20.09$1.0M1,122,626(D)

View →

May 13, 2026May 15 8:45 PMYing DuDirector, Chairperson & CEO
Sale
50,000$19.97$998.5K1,122,626(D)

View →

May 15, 2026May 15 1:49 PMDu Ying
Proposed Sale
50,000$20.46$1.0M

View →

May 14, 2026May 14 8:17 PMDu Ying
Proposed Sale
50,000$20.09$1.0M

View →

May 14, 2026May 14 1:50 PMEdmondson Frazor Titus III
Proposed Sale
3,517$20.19$71.0K

View →

May 13, 2026May 13 6:06 PMDu Ying
Proposed Sale
50,000$19.20$960.0K

View →

Apr 6, 2026Apr 8 11:35 PMJoshua L SmileyPresident and Chief Operating Officer
Sale
3,017$20.45$61.7K117,602(D)

View →

Apr 6, 2026Apr 8 11:34 PMFrazor Titus Edmondson IIIChief Legal Officer
Sale
1,224$20.45$25.0K23,366(D)

View →

Apr 6, 2026Apr 8 11:34 PMYing DuDirector, Chairperson & CEO
Sale
2,653$20.45$54.2K1,122,626(D)

View →

Apr 6, 2026Apr 8 11:33 PMYajing ChenChief Financial Officer
Sale
853$20.45$17.4K31,705(D)

View →

Apr 6, 2026Apr 8 11:33 PMRafael AmadoPresident, Head of Global Oncology Research and Development
Sale
2,739$20.45$56.0K57,022(D)

View →

Apr 6, 2026Apr 6 7:26 PMSmiley Joshua L
Proposed Sale
3,017$20.45$61.7K

View →

Apr 6, 2026Apr 6 7:21 PMDu Ying
Proposed Sale
2,653$20.45$54.2K

View →

Apr 6, 2026Apr 6 7:15 PMEdmondson Frazor Titus III
Proposed Sale
1,224$20.45$25.0K

View →

Apr 6, 2026Apr 6 7:11 PMAmado Rafael
Proposed Sale
2,739$20.45$56.0K

View →

Apr 6, 2026Apr 6 7:04 PMChen Yajing
Proposed Sale
853$20.45$17.4K

View →

Page 1 of 6

Next →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 11, 2026Jun 8 8:29 PMYizhe WangOperating Partner
Grant/Award
196,107$20.3259,288(D)

View →

May 19, 2026May 21 8:19 PMYing DuDirector, Chairperson & CEO
Option Exercise
261,092$1.740(D)

View →

May 18, 2026May 19 8:18 PMYing DuDirector, Chairperson & CEO
Option Exercise
50,000$1.74261,092(D)

View →

May 15, 2026May 19 8:18 PMYing DuDirector, Chairperson & CEO
Option Exercise
50,000$1.74311,092(D)

View →

May 14, 2026May 15 8:45 PMYing DuDirector, Chairperson & CEO
Option Exercise
50,000$1.74361,092(D)

View →

May 13, 2026May 15 8:45 PMYing DuDirector, Chairperson & CEO
Option Exercise
50,000$1.74411,092(D)

View →

Apr 2, 2026Apr 3 9:59 PMJoshua L SmileyPresident and Chief Operating Officer
Option Exercise
7,1457,145(D)

View →

Apr 1, 2026Apr 3 9:59 PMJoshua L SmileyPresident and Chief Operating Officer
Option Exercise
32,06264,125(D)

View →

Mar 4, 2026Apr 3 9:59 PMJoshua L SmileyPresident and Chief Operating Officer
Grant/Award
17,88717,887(D)

View →

Apr 2, 2026Apr 3 9:58 PMFrazor Titus Edmondson IIIChief Legal Officer
Option Exercise
5,0315,032(D)

View →

Apr 1, 2026Apr 3 9:58 PMFrazor Titus Edmondson IIIChief Legal Officer
Option Exercise
17,25927,516(D)

View →

Mar 4, 2026Apr 3 9:58 PMFrazor Titus Edmondson IIIChief Legal Officer
Grant/Award
11,92411,924(D)

View →

Apr 2, 2026Apr 3 9:58 PMYing DuDirector, Chairperson & CEO
Option Exercise
6,75013,500(D)

View →

Apr 1, 2026Apr 3 9:58 PMYing DuDirector, Chairperson & CEO
Option Exercise
14,2000(D)

View →

Mar 4, 2026Apr 3 9:58 PMYing DuDirector, Chairperson & CEO
Grant/Award
25,57925,579(D)

View →

Apr 2, 2026Apr 3 9:57 PMYajing ChenChief Financial Officer
Option Exercise
2,5002,500(D)

View →

Apr 1, 2026Apr 3 9:57 PMYajing ChenChief Financial Officer
Option Exercise
15,25827,516(D)

View →

Mar 4, 2026Apr 3 9:57 PMYajing ChenChief Financial Officer
Grant/Award
11,92411,924(D)

View →

Apr 2, 2026Apr 3 9:57 PMRafael AmadoPresident, Head of Global Oncology Research and Development
Option Exercise
5,3915,391(D)

View →

Apr 1, 2026Apr 3 9:57 PMRafael AmadoPresident, Head of Global Oncology Research and Development
Option Exercise
19,52339,046(D)

View →

Page 1 of 2

Next →